ARHGAP42 and hypertensive disorder: When combined with a growing body of evidence that patient-specific eQTLs in the GRAF3 gene are associated with human hypertension [19,47,48,49], these studies suggest that GRAF3 might be an attractive target for the treatment of HTN.